Mikobakteriyel Enfeksiyonlarda Konağa Ait Faktörler
Referanslar
World Health Organization. Global tuberculosis report 2025 (Internet). Geneva: World Health Organization; 2025. (02/05/2026 tarihinde who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025 adresinden ulaşılmıştır).
Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS medicine. 2016;13(10):e1002152.
Emery JC, Richards AS, Dale KD, et al. Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease. Proceedings of the Royal Society B. 2021;288(1943):20201635.
Asgharzadeh V, Seyyed Rezaei SA, Asgharzadeh M, et al. Host risk factors for tuberculosis. Infectious Disorders Drug Targets. 2025;25(4):e18715265304343. doi:10.2174/0118715265304343240722190414
Brailey M. A study of tuberculous infection and mortality in the children of tuberculous households. American Journal of Epidemiology. 1940;31(1):1–43.
Perez-Velez CM, Marais BJ. Tuberculosis in children. New England Journal of Medicine. 2012;367(4):348–361. doi:10.1056/NEJMra1008049
Narasimhan P, Wood J, MacIntyre CR, et al. Risk factors for tuberculosis. Pulmonary Medicine. 2013;2013:828939. doi:10.1155/2013/828939
Rajagopalan S. Tuberculosis and aging: a global health problem. Clinical Infectious Diseases. 2001;33(7):1034-1039.
Rickman HM, Phiri MD, Feasey HRA, et al. Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys. The Lancet Public Health. 2025;10:e588-e598.
Chiang CY, Slama K, Enarson DA. Associations between tobacco and tuberculosis. International Journal of Tuberculosis and Lung Disease. 2007;11:258–262.
Gupta M, Srikrishna G, Klein SL, et al. Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends in Immunology. 2022;43(8):640-656.
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine. 2007;175(4):367-416.
The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardized treatment. International Journal of Tuberculosis and Lung Disease. 2002;6(7):628–634.
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern: the Lady Windermere Syndrome. Chest. 1992;101:1605-1609.
Wang L, Noertjojo K, Elwood RK, et al. Tuberculosis among aboriginal and nonaboriginal persons in British Columbia. Canadian Respiratory Journal. 2000;7(2):151–157. doi:10.1155/2000/764721
Plant AJ, Krause VL, Condon JR, et al. Aborigines and tuberculosis: why they are at risk. Australian Journal of Public Health. 1995;19(5):487–491.
Clark M, Vynnycky E. The use of maximum likelihood methods to estimate the risk of tuberculous infection and disease in a Canadian First Nations population. International Journal of Epidemiology. 2004;33(3):477–484. doi:10.1093/ije/dyh001.
Greenwood CMT, Fujiwara TM, Boothroyd LJ, et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. American Journal of Human Genetics. 2000;67(2):405–416. doi:10.1086/303012.
World Health Organization (2011). Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. World Health Organization. https://iris.who.int/handle/10665/44472
Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harbor Perspectives in Medicine. 2015;5(7):a017871. doi: 10.1101/cshperspect.a017871
National Institutes of Health Panel on Opportunistic Infections in Adults and Adolescents with HIV. Disseminated Mycobacterium avium complex disease (Internet). Bethesda: National Institutes of Health; 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/disseminated. Erişim tarihi: 01.04.2026.
Murray PR, Rosenthal KS, Pfaller MA. Mycobacteria. In: Medical microbiology. 8th ed. Philadelphia: Elsevier Saunders; 2015.
Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nature Reviews Immunology. 2001;1(1):20-30. doi: 10.1038/35095558.
Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. Journal of Immunology. 1996;157(3):1271–1278.
Gardam MA. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infectious Diseases. 2003;3(3):148–155. doi: 10.1016/s1473-3099(03)00545-0
Cisneros JR, Murray KM. Corticosteroids in tuberculosis. Annals of Pharmacotherapy. 1996;30(11):1298–1303. doi: 10.1177/106002809603001115
Shu CC, Tsai MK, Lin SW, et al. Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: a neglected perspective in tuberculosis control. Clinical Infectious Diseases. 2020;71:914–923.
Prasad P, Sharma S, Mohanasundaram S, et al. Tuberculosis in kidney transplant candidates and recipients. World Journal of Transplantation. 2024;14(3):96225. doi:10.5500/wjt.v14.i3.96225
Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clinical Infectious Diseases. 1998;27:1266–1277. doi:10.1086/514993.
Jonsson J, Kühlmann-Berenzon S, Berggren I, et al. Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden. European Respiratory Journal. 2020;55:1901886. doi: 10.1183/13993003.01886-2019
Nepesov S, Camcıoğlu Y. Mikobakteriyel hastalıklara Mendelyen duyarlılık. Klinik Tıp Pediatri Dergisi. 2020;12(3):147–153
Rosain J, Kong XF, Martinez-Barricarte R, et al. Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunology and Cell Biology. 2019;97:360–367. doi: 10.1111/imcb.12210
Casanova JL, Abel L. Lethal infectious diseases as inborn errors of immunity: toward a synthesis of the germ and genetic theories. Annual Review of Pathology. 2021;16:23–50. doi:10.1146/annurev-pathol-031920-101429.
Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Human Genetics. 2020;139(6–7):993–1000. doi:10.1007/s00439-020-02120-y
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. Journal of Allergy and Clinical Immunology. 2014;133(4):1134–1141. doi: 10.1016/j.jaci.2014.02.028.
Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809-821.
Conti F, Lugo-Reyes SO, Blancas-Galicia L, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. Journal of Allergy and Clinical Immunology. 2016;138(1):241–248. doi: 10.1016/j.jaci.2015.11.041
McNicholl JM, Downer MV, Lidhayakumar V, et al. Host-pathogen interactions in emerging and reemerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B and cholera. Annual Review of Public Health. 2000;21:15–46. doi: 10.1146/annurev.publhealth.21.1.15.
Karahan ZC, Akar N. Tüberküloza genetik yatkınlık. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2002;55(2):151–162.
Schurz H, Naranbhai V, Yates TA, et al. Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture. eLife. 2024;13:e84394. doi:10.7554/eLife.84394.
Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infection and Immunity. 2012;80(10):3343–3359. doi:10.1128/IAI.00443-12.
Hu B, Wang Y, Wang Z, et al. Association of SLC11A1 polymorphisms with tuberculosis susceptibility in the Chinese Han population. Frontiers in Genetics. 2022;13:899124. doi:10.3389/fgene.2022.899124.
Li XW, Yang Y, Zhou F, et al. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLOS ONE. 2011;6(1):e15831. doi:10.1371/journal.pone.0015831.
Gao L, Tao Y, Zhang L, et al. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease. 2010;14(1):15–23.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine. 2008;5(7):e152. doi:10.1371/journal.pmed.0050152
Barry SE, Sawka A, Maldari A, et al. Macrophage dysfunction in tuberculosis-diabetes mellitus comorbidity: a scoping review of immune dysregulation and disease progression. Diabetology. 2025;6(5):35.
Hauser AB, Stinghen AEM, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Peritoneal Dialysis International. 2008;28(Suppl 3):S183–S187
Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Seminars in Dialysis. 2003;16(1):38–44. doi:10.1046/j.1525-139X.2003.03010.x.
Alemu A, Bitew ZW, Diriba G, et al. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2022;122:188–201.
Sturman J, Baharani J, Ashman J, et al. Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK. Clinical Kidney Journal. 2025;18(7):sfaf197. doi:10.1093/ckj/sfaf197
Cheng MP, Abou Chakra CN, Yansouni CP, et al. Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis. Clinical Infectious Diseases. 2017;64(5):635–644.
Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clinics in Chest Medicine. 2015;36(1):91–99. doi:10.1016/j.ccm.2014.11.002
Hamada Y, Fong CJ, Copas A, et al. Risk for development of active tuberculosis in patients with chronic airway disease: a systematic review of evidence. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022;116(5):390–398. doi:10.1093/trstmh/trab122.
Ruzangi J, Iwagami M, Smeeth L, et al. The association between chronic kidney disease and tuberculosis: a comparative cohort study in England. BMC Nephrology. 2020;21:420.
Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. American Journal of Respiratory and Critical Care Medicine. 1994;150(5 Pt 1):1460–1462.
Farazi A, Jabbariasl M. Silico-tuberculosis and associated risk factors in central province of Iran. Pan African Medical Journal. 2015;20:333.
Sarkar B, Sarkar K. End tuberculosis strategy also requires initiation and integration of a national silicosis control program with the ongoing tuberculosis elimination activities: a review of the silicotuberculosis situation in India. Journal of Biological Methods. 2024;11(4):e99010035. doi:10.14440/jbm.2024.0053.
Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1–i22.
Levy I, Grisaru-Soen G, Lerner-Geva L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections in patients with cystic fibrosis. Emerging Infectious Diseases. 2008;14(3):378–384. doi:10.3201/eid1403.061405
Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Archives of Internal Medicine. 2007;167(4):335–342.
Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Medicine. 2007;4(1):e20. doi: 10.1371/journal.pmed.0040020
Fok A, Numata Y, Schulzer M, FitzGerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. International Journal of Tuberculosis and Lung Disease. 2008;12(5):480-492.
Lönnroth K, Williams BG, Stadlin S, et al. Alcohol use as a risk factor for tuberculosis: a systematic review. BMC Public Health. 2008;8:289. doi: 10.1186/1471-2458-8-289.
Szabo G. Alcohol's contribution to compromised immunity. Alcohol Research and Health. 1997;21(1):30-38.
Silva DR, Muñoz-Torrico M, Duarte R, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. Jornal Brasileiro de Pneumologia. 2018;44(2):145–152. doi:10.1590/S1806-37562017000000443
Mishra VK, Retherford RD, Smith KR. Biomass cooking fuels and prevalence of tuberculosis in India. International Journal of Infectious Diseases. 1999;3(3):119-129.
Perez-Padilla R, Perez-Guzman C, Baez-Saldana R, et al. Cooking with biomass stoves and tuberculosis: a case control study. International Journal of Tuberculosis and Lung Disease. 2001;5(5):441–447.
Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case-control study. Thorax. 2009;64(8):705-708. doi: 10.1136/thx.2008.109405
Cegielski JP, McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. International Journal of Tuberculosis and Lung Disease. 2004;8(3):286–298.
Comstock GW, Palmer CE. Long-term results of BCG vaccination in the southern United States. American Review of Respiratory Disease. 1966;93(2):171–183. doi: 10.1164/arrd.1966.93.2.171.
Cegielski JP, Kohlmeier L, Cornoni-Huntley J. Malnutrition and tuberculosis in a nationally representative cohort of adults in the United States, 1971–1987. In: Proceedings of the 44th Annual Meeting of the American Society of Tropical Medicine and Hygiene. American Society of Tropical Medicine and Hygiene; 1995. p.152.
Lönnroth K, Williams BG, Cegielski P, et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. International Journal of Epidemiology. 2010;39:149–155. doi:10.1093/ije/dyp308.
Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Social Science and Medicine. 2009;68(12):2240–2246. doi: 10.1016/j.socscimed.2009.03.041.
Muniyandi M, Ramachandran R, Gopi PG, et al. The prevalence of tuberculosis in different economic strata: a community survey from South India. International Journal of Tuberculosis and Lung Disease. 2007;11(9):1042–1045.
O’Grady J, Maeurer M, Atun R, et al. Tuberculosis in prisons: anatomy of global neglect. European Respiratory Journal. 2011;38(4):752–754. doi: 10.1183/09031936.00041211.
Uden L, Barber E, Ford N, et al. Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis. Open Forum Infectious Diseases. 2017;4(3):ofx137. doi:10.1093/ofid/ofx137.